February 17, 2026

Concentra Group Holdings (CON): Analyst Ratings Signal 21% Upside in Healthcare Stock

For investors seeking opportunities within the healthcare sector, Concentra Group Holdings Parent (CON) offers an intriguing proposition. Headquartered in Addison, Texas, Concentra has carved out a significant niche in the..

Crinetics Pharmaceuticals, Inc. (CRNX): Investor Outlook with a 99% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a clinical-stage biotech firm focused on pioneering treatments for rare endocrine diseases, is capturing the attention of savvy investors with a staggering potential upside of..

Addus HomeCare Corporation (ADUS) Stock Analysis: 23.9% Upside Potential Makes It a Compelling Buy

Addus HomeCare Corporation (NASDAQ: ADUS), a prominent player in the healthcare sector, is drawing investor attention with its robust growth trajectory and promising analyst ratings. The company, headquartered in Frisco,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Evaluating a 25% Upside Potential in the Biotech Sector

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline and notable potential for growth. With a market capitalization of..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Potential 75% Upside in the Biotech Sector

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a market capitalization of $2.93 billion, focusing on developing therapeutics for neurodegenerative and lysosomal storage diseases. Despite its..

Veracyte, Inc. (VCYT) Stock Analysis: Unpacking a Potential 33% Upside for Investors

Veracyte, Inc. (VCYT), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers a compelling opportunity for investors seeking growth in the innovative field of..

Alvotech (ALVO): A 378% Upside Potential in the Biosimilar Market

Alvotech (ALVO), a prominent player in the healthcare sector specializing in the development and manufacturing of biosimilar medicines, presents a compelling investment opportunity with a staggering 377.73% potential upside according..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Navigating Growth in the Generic Drug Market

Investors with an eye on the healthcare sector might find Amneal Pharmaceuticals, Inc. (AMRX) a compelling prospect, especially as the company makes significant strides in the competitive landscape of generic..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Potential in the Dental Market

Envista Holdings Corporation (NYSE: NVST) is a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista has carved a niche..

QuidelOrtho Corporation (QDEL): Analyzing Its 47% Potential Upside in the Medical Devices Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in San Diego, California, the company delivers diagnostic testing solutions that..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 27% Upside Potential in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out in the biotechnology industry with a market cap of $5.58 billion and a focus on developing treatments for rare disorders. As the company..

ImmunityBio, Inc. (IBRX)

⚠️ No article content returned.

..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 190% Potential Upside Awaits Investors

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a pioneering biopharmaceutical company, stands at the forefront of developing therapies for rare and ultra-rare genetic diseases. Based in Novato, California, the company is renowned..

Surgery Partners, Inc. (SGRY) Stock Analysis: Is the 64.65% Upside Potential Within Reach?

Surgery Partners, Inc. (NASDAQ: SGRY) stands as a notable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2 billion, this Brentwood,..

ICU Medical, Inc. (ICUI) Investor Outlook: 24.8% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the medical instruments and supplies industry, offers a compelling prospect for investors seeking exposure to the healthcare sector. Based in San..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

Arbuthnot Latham reinforces relationship banking strategy

Arbuthnot Latham’s 2025 client survey highlights sustained satisfaction and advocacy, underlining the strength of its relationship driven banking model...

Sintana Energy Initiated at Buy with 62p Target Price, Cavendish Highlights “Walking amongst giants” Opportunity

Sintana Energy initiated at Buy by Cavendish with 62p target price, highlighting Mopane upside and strong exploration catalysts...

FTSE 100 advances as investors weigh data signals and policy outlook

UK equities opened the week firmer as investors balanced steady sterling, softer gilt yields and upcoming economic data that could shape the next phase of monetary policy...

Tungsten moves to the centre of critical minerals strategy

Investor interest in tungsten is rising as governments prioritise secure, diversified supply for critical industries...
Search

Funds

February 17, 2026

Arbuthnot Latham reinforces relationship banking strategy

Arbuthnot Latham’s 2025 client survey highlights sustained satisfaction and advocacy, underlining the strength of its relationship driven banking model...

Sintana Energy Initiated at Buy with 62p Target Price, Cavendish Highlights “Walking amongst giants” Opportunity

Sintana Energy initiated at Buy by Cavendish with 62p target price, highlighting Mopane upside and strong exploration catalysts...

FTSE 100 advances as investors weigh data signals and policy outlook

UK equities opened the week firmer as investors balanced steady sterling, softer gilt yields and upcoming economic data that could shape the next phase of monetary policy...

Tungsten moves to the centre of critical minerals strategy

Investor interest in tungsten is rising as governments prioritise secure, diversified supply for critical industries...
Search

Funds

February 17, 2026

FTSE 100

Funds